Testosterone does not fall off a cliff on a man’s 40th birthday. The decline is gradual, beginning in the late 20s and accelerating through the 40s and 50s. But the downstream effects on energy, body composition, cognitive function, and sexual health are real and measurable. Understanding what is actually happening hormonally after 40 helps men make informed decisions rather than accepting progressive decline as inevitable. ( 1 )
How Testosterone Works in the Male Body
Testosterone is produced primarily in the Leydig cells of the testes under direction from the hypothalamic-pituitary-gonadal (HPG) axis. The hypothalamus releases gonadotropin-releasing hormone (GnRH), which signals the pituitary to secrete luteinizing hormone (LH) and follicle-stimulating hormone (FSH). LH then stimulates the Leydig cells to produce testosterone. ( 2 )
Testosterone circulates in three forms: free testosterone (biologically active), testosterone bound to sex hormone-binding globulin (SHBG, largely inactive), and testosterone loosely bound to albumin (partially bioavailable). Total testosterone labs capture all three forms. Free testosterone, which represents only 2 to 3 percent of the total, is what actually drives the biological effects men associate with healthy hormonal function. ( 3 )
What Changes After 40
After age 40, several hormonal shifts converge. Total testosterone declines at roughly 1 to 2 percent per year. ( 4 ) Simultaneously, SHBG levels rise with age, which means an even greater proportion of total testosterone is bound and unavailable. This is why some men have testosterone lab values in the low-normal range but still experience clear symptoms: their free testosterone is disproportionately low. ( 5 )
LH pulsatility also changes. The hypothalamus sends fewer and less robust GnRH pulses, reducing the downstream stimulus for testicular production. Testicular volume and Leydig cell number decline modestly but meaningfully over decades. ( 6 ) The combined effect is a sustained reduction in both production capacity and hormonal bioavailability. For reference on what these numbers look like across the lifespan, see this breakdown of normal testosterone levels by age.
The Science Behind Age-Related Hormonal Decline
The most rigorous large-scale data on male hormonal aging comes from the Massachusetts Male Aging Study (MMAS), which tracked hormonal changes in a community-based cohort of men over several decades. The study found that total testosterone declined at an average rate of approximately 1.6 percent per year after age 39, independent of health status and lifestyle. ( 7 )
Inflammation accelerates this process. Chronic low-grade inflammation, common in men with poor diet, elevated visceral fat, or sedentary behavior, suppresses the HPG axis at multiple levels. Inflammatory cytokines directly inhibit GnRH secretion and impair Leydig cell steroidogenesis. ( 8 ) This creates a compounding cycle: lower testosterone increases fat accumulation, elevated adiposity increases aromatase activity (converting testosterone to estrogen), and higher estrogen further suppresses the HPG axis. ( 9 )
Sleep deprivation is another potent suppressor. The majority of daily testosterone production occurs during sleep, particularly during slow-wave and REM stages. A study published in JAMA found that healthy young men who slept fewer than five hours per night for one week showed testosterone levels 10 to 15 percent lower than their baseline. The relationship between sleep quality and testosterone is detailed further at does sleep affect testosterone. ( 10 )
Benefits of Maintaining Testosterone in the Optimal Range
Testosterone is not just about libido. Its systemic effects span nearly every tissue type in the male body:
- Muscle mass and strength: Testosterone drives protein synthesis and satellite cell activation. Men with low testosterone lose muscle mass faster and respond more poorly to resistance training. ( 11 )
- Bone density: Testosterone is converted to estradiol in bone tissue, where it suppresses osteoclast activity. Low testosterone is directly associated with increased fracture risk in aging men. ( 12 )
- Cognitive function: Testosterone receptors are expressed throughout the brain, including in regions associated with memory and executive function. Longitudinal studies have found associations between low testosterone and increased risk of cognitive decline. ( 13 )
- Cardiovascular health: The evidence is nuanced, but physiological testosterone levels support insulin sensitivity, reduce visceral fat, and improve endothelial function. Severely low testosterone is associated with metabolic syndrome and elevated cardiovascular risk. ( 14 )
- Mood and motivation: Testosterone modulates dopaminergic and serotonergic pathways. Low testosterone is consistently associated with depressive symptoms, reduced motivation, and low energy in middle-aged men. ( 15 )
Common Myths and Misconceptions
Myth: Low testosterone is just a normal part of aging you have to accept
Decline is normal in the statistical sense, meaning it is common. That does not make it inevitable or untreatable. Lifestyle interventions and, where indicated, medical therapies can restore testosterone to levels that support quality of life. The distinction between what is typical and what is optimal matters. ( 16 )
Myth: Testosterone therapy causes heart attacks
This concern stems from a 2010 trial that was halted early and later criticized heavily for methodology. Subsequent large-scale studies, including the TRAVERSE trial published in 2023 in the New England Journal of Medicine, found no significant increase in major cardiovascular events in men with low testosterone who received testosterone replacement therapy. ( 17 )
Myth: Natural boosters are always safer than TRT
Many marketed “testosterone boosters” have limited or no clinical evidence for meaningfully raising testosterone in hypogonadal men. The comparison between natural approaches and medical therapy depends entirely on the individual’s baseline levels and health context. A thorough review of this comparison is available at TRT vs natural testosterone boosters. ( 18 )
When to Evaluate Your Hormonal Health
Any man over 35 experiencing persistent fatigue, unexplained fat gain (especially abdominal), declining strength despite training, reduced libido, or mood changes without an obvious cause should have testosterone levels assessed. Testing should include total testosterone, free testosterone, SHBG, LH, FSH, estradiol, and a complete metabolic panel. A single morning draw is required, as testosterone follows a diurnal rhythm with peak levels occurring between 7 and 10 AM. ( 19 )
Men confirmed to have clinical hypogonadism have two primary pathways: lifestyle optimization and medical therapy. Understanding what each involves is the foundation of any decision. Start with an honest look at what low testosterone means clinically before drawing conclusions from a single lab result.
The Next Step
Hormonal aging in men is well-characterized, treatable, and no longer a topic that belongs only in conversations about fertility or sexual dysfunction. If your energy, body composition, and mental sharpness are not where they were five years ago, your hormonal environment is a legitimate place to start the investigation. The data exists. The clinical tools exist. The only gap is the decision to look.
Emergency Notice: If you or someone else is experiencing a medical emergency, call 911 immediately. The information on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
References
- Harman SM, et al. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab. 2001;86(2):724-731.
- Bhasin S, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744.
- Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84(10):3666-3672.
- Feldman HA, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 2002;87(2):589-598.
- Winters SJ, et al. Inhibin B and testosterone levels in aging men. J Clin Endocrinol Metab. 2003;88(9):4196-4201.
- Zirkin BR, Tenover JL. Aging and declining testosterone: past, present, and hopes for the future. J Androl. 2012;33(6):1111-1118.
- Travison TG, et al. The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. J Clin Endocrinol Metab. 2007;92(2):549-555.
- Dandona P, Rosenberg MT. A practical guide to male hypogonadism in the primary care setting. Int J Clin Pract. 2010;64(6):682-696.
- Cohen PG. Aromatase, adiposity, aging and disease: the hypogonadal-metabolic-atherogenic-disease and aging connection. Med Hypotheses. 2001;56(6):702-708.
- Leproult R, Van Cauter E. Effect of 1 week of sleep restriction on testosterone levels in young healthy men. JAMA. 2011;305(21):2173-2174.
- Bhasin S, et al. Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab. 2001;281(6):E1172-E1181.
- Fink HA, et al. Association of testosterone and estradiol deficiency with osteoporosis and rapid bone loss in older men. J Clin Endocrinol Metab. 2006;91(10):3908-3915.
- Moffat SD, et al. Free testosterone and risk for Alzheimer disease in older men. Neurology. 2004;62(2):188-193.
- Traish AM, et al. The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance. J Androl. 2009;30(1):23-32.
- Shores MM, et al. Low serum testosterone and mortality in male veterans. Arch Intern Med. 2006;166(15):1660-1665.
- Buvat J, et al. Late-onset hypogonadism: a review. World J Urol. 2012;30(3):341-348.
- Lincoff AM, et al. Cardiovascular safety of testosterone-replacement therapy. N Engl J Med. 2023;389(2):107-117.
- Bhasin S, Basaria S. Diagnosis and treatment of hypogonadism in men. Best Pract Res Clin Endocrinol Metab. 2011;25(2):251-270.
- Brambilla DJ, et al. The effect of diurnal variation on clinical measurement of serum testosterone and other sex hormone levels in men. J Clin Endocrinol Metab. 2009;94(3):907-913.